Recipharm acquires OnTarget Chemistry and extends its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Recipharm acquires OnTarget Chemistry and extends its offering into preclinical development services

Recipharm today announces that it has completeted the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company with a turnover in 2014 of close to SEK 29 million that is specialized in medicinal chemistry offering synthesis and analytical services which include rare and demanding specialties. With the acquisition of OnTarget Chemistry, Recipharm will significantly broaden its pharmaceutical development capabilities. The inclusion of preclinical chemistry services will give Recipharm the possibility to engage much earlier in high potential customer projects. Furthermore, OnTarget Chemistry’s synthesis capabilities will be of great value for the GMP development of APIs in Recipharm’s Italian subsidiary, Edmond Pharma. Sales in 2015 show more than 60 % of total revenue outside Sweden with substantial sales in Germany, Japan and the UK. The business is profitable and the acquisition is expected to be accretive to EPS from 2016 Carl-Johan Spak, EVP of Development & Technology commented, “With the acquisition of OnTarget Chemistry we will be able serve both existing and new customers with high quality development services. OnTarget Chemistry has a very skilled staff with a high number of PhDs working in a modern laboratory of very high standard. The acquisition is of strategic importance for Recipharm as it will together with the existing development organisation fuel manufacturing sales in the long term. Fredrik Lehmann, CEO of OnTarget Chemistry added “The fit with Recipharm’s development organisation is very good for us. We believe we can add preclinical competence and capabilities to Recipharm and we also look forward to contributing with a broad range of both local and international customers. This will be a great opportunity for us to continue to grow our business within Recipharm”. The purchase price was SEK 15.1 million, of which 50% is paid in cash and the remaining 50% is paid through an issue in kind of 45.838 series B shares in Recipharm. The share issue was resolved upon 15 June 2015 by the board of directors of Recipharm, based on an authorization given by the AGM 7 May 2015. Approximately 36% of the B shares in Recipharm the seller receives are subject to a lock-up of 2 years. The remaining B shares will be distributed by the seller to certain individuals that contributed their shares in OnTarget Chemistry to the seller before the transaction was consummated. For more information please visit www.recipharm.com or contact: Thomas Eldered, CEO Recipharm, thomas.eldered@recipharm.com, + 46 8 602 52 10 Carl-Johan Spak, EVP D&T, carl-johan.spak@recipharm.com, telephone: +46 8 602 53 13 For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on: E-mail: t.jervis@defacto.com  (t.jervis@defacto.com%20)or a.heeley@defacto.com, Tel: +44 (0) 207 861 3019/3043 This information is published in accordance with the Swedish Securities Market Act, the Swedish Financial Instruments Trading Act and/or the regulations of NASDAQ Stockholm. This information was submitted for publication on 15 June 2015, at 13:00 CET. About Recipharm Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 2,200 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material including API and pharmaceutical product development. Recipharm manufactures more than 400 different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 3.3 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For more information on Recipharm and our services, please visit www.recipharm.com About OnTarget Chemistry OnTarget Chemistry is a chemistry contract research organization (CRO) that offers premium quality synthetic and analytical chemistry services performed by a professional and experienced team of predominately PhD. level chemists with pharma backgrounds. The company is headquartered in Sweden with marketing presence in US, Japan, UK, Finland, Germany and France and has an U.S. office in Chicago since 2013. For further information visit http://www.ontargetchemistry.com Recipharm AB (publ) Corporate identity number 556498-8425 Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03 www.recipharm.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 81

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 107

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 99

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 86

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 95

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 98

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 39

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 136

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 29

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 85

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading

Top 5 Most Recently Viewed Articles

Cascade Milling Enhances Operations with New Facility Expansion

Updated Category News Views 988

Expansion Plans at Cascade Milling Cascade Milling is thrilled to announce the expansion of its organic flour milling facility. This extensive enhancement involves adding a new building dedicated to boosting production. With organic products becoming increasingly popular, this expansion will help the company meet the growing demands for quality organic flours, grains, and...

Continue Reading
Dollar Tree's Stock Trends: What Investors Should Know Now

Updated Category News Views 158

Dollar Tree Inc. Stock Shows Promising Growth Dollar Tree Inc. (NASDAQ: DLTR) shares are experiencing upward movement recently, indicating a possible emerging trend. Notably, the stock seems to be gaining momentum. Market Dynamics and Recent Developments After being deemed oversold, Dollar Tree's stock has gained interest, particularly following recent earnings reports...

Continue Reading
Important Update for Workhorse Group Shareholders About Call

Updated Category News Views 141

Engaging Shareholders Ahead of Upcoming Conference Call In a crucial step to engage with shareholders, Workhorse Group Inc. (Nasdaq: WKHS) is gearing up for a conference call designed to address significant updates. This call is an opportunity for shareholders to discuss the company's important financial results and recently announced transactions. Call Details for...

Continue Reading
LeafLink's Strategic Acquisition of Leaf Trade to Boost Growth

Updated Category News Views 222

LeafLink Expands Horizons with Leaf Trade Acquisition LeafLink, a prominent name in the cannabis wholesale industry, has recently made headlines with its acquisition of Leaf Trade. This strategic move is set to create a significant impact on the market by streamlining operations and addressing the growing needs of multi-state operators (MSOs) and enterprise-level cannabis...

Continue Reading
Florida's First Behavioral Health Teaching Hospital Unveiled

Updated Category News Views 189

Welcoming Florida's First Behavioral Health Teaching Hospital The TGH Behavioral Health Hospital represents a significant milestone in mental health treatment. This facility offers specialized and personalized care for various behavioral and mental health conditions. Inauguration Ceremony at TGH Recently, leaders from Tampa General Hospital (TGH), Lifepoint Health, and...

Continue Reading